Accelerated telomere shortening and telomerase activation in Fanconi's anaemia
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Fanconi's anaemia (FA) is an autosomal recessive disorder characterized by progressive bone marrow failure that often evolves towards acute leukaemia. FA also belongs to a group of chromosome instability diseases. Because telomeres are directly involved in chromosomal stability and in cell proliferation capacity, we examined telomere metabolism in peripheral blood mononuclear cells (PBMC). Telomere length was significantly shorter in 54 FA patient samples, compared to 51 controls (P<0.0001). In addition, mean telomere terminal restriction fragment lengths (TRF) in nine heterozygous patient samples did not differ from those of controls. In 14 samples from FA patients with severe aplastic anaemia (SFA), telomere length was significantly shorter than in 22 samples of age‐matched FA patients with moderate haematological abnormalities (NSFA) (P<0.001). However, no correlation was found between TRF length and the presence of bone marrow clonal abnormalities in 16 additional, separately analysed, patient samples. Sequential measurement of TRF in six FA patients showed an accelerated rate of telomere shortening. Accordingly, telomere shortening rate was inversely correlated with clinical status. Telomerase, the enzyme that counteracts telomere shortening, was 4.8‐fold more active in 25 FA patients than in 15 age‐matched healthy controls. A model for the FA disease process is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784 · cited 1×
“Its activity is highly controlled and downregulated in most human tissues, but re-expressed in cancer cells (Meyerson et al, 1997), including leukaemia (Shay et al, 1996).”
BackgroundTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709 · cited 2×
“Indeed, we expected TRF shortening to increase genomic instability, since TRF2, a telomere binding protein, had recently been shown to reduce genomic instability by capping chromosome extremities (Vansteensel et al, 1998).”
BackgroundEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 5×
“…could first slow down and then stop the cell cycle machinery, as seen in telomerase knock-out mice upon q 1999 Blackwell Science Ltd, British Journal of Haematology 105: 883–893 q 1999 Blackwell Science Ltd, British Journal of Haematology 105: 883–893 erosion of their telomeres (Lee et al, 1998).”
BackgroundInfluentialEvidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9857 · Cited by 1,132 · cited 3×
“Telomere shortening with age in control individuals, including cord blood samples, was 60 6 9 bp per year (n ¼ 51, Fig 1), a value consistent with previous studies (Akiyama et al, 1998; Engelhardt et al, 1998; Iwama et al, 1998; Vaziri et al, 1994).”
BackgroundResultHuman telomeres contain two distinct Myb–related proteins, TRF1 and TRF2
Broccoli, D., Smogorzewska, A., Chong, L., & de Lange, T. (1997) · Nature Genetics · doi:10.1038/ng1097-231 · Cited by 926 · cited 1×
“This activation is expected to result from the loss of negative feedback control involving TRF1, a telomerebinding protein (Broccoli et al, 1997).”
BackgroundActivation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853 · cited 2×
“Telomerase activity in PBMC cells Telomerase, the enzyme that counteracts telomere shortening, has been shown to be present in most normal haemopoietic cells (Hiyama et al, 1995).”
BackgroundThe rate of telomere sequence loss in human leukocytes varies with age
Frenck, R. W., Blackburn, E. H., & Shannon, K. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5607 · Cited by 675
Preferential Accumulation of Single-Stranded Regions in Telomeres of Human Fibroblasts
Petersen, S., Saretzki, G., & Zglinicki, T. V. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3893 · Cited by 427 · cited 1×
“These include direct creation of DNA breaks in telomeres by the formation of free radicals under conditions of hyperoxia (Petersen et al, 1998; Vaziri et al, 1997) and pathologies caused by alteration of one of the proteins involved in telomere metabolism, such as in ataxia telangiectasia (Metcalfe…”
BackgroundT Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4 + T Cell Turnover
Wolthers, K. C., Bea, G., Wisman, A., Otto, S. A., de Roda Husman, A.-M., Schaft, N., de Wolf, F., Goudsmit, J., Coutinho, R. A., van der Zee, A. G. J., et al. (1996) · Science · doi:10.1126/science.274.5292.1543 · Cited by 286
Cited by
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Aubert, G., & Lansdorp, P. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00026.2007 · Cited by 1,188
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 603
T cells and aging january 2002 update
Pawelec, G. (2002) · Frontiers in Bioscience · doi:10.2741/a831 · Cited by 369
Alter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356
Metadata
- Authors
- Leteurtre, F., Li, X., Guardiola, P., Le Roux, G., Sergère, J. ‐., Richard, P., Carosella, E. D., & Gluckman, E.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 105
- Issue
- 4
- Pages
- 883-893
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2075700583
- Cited by
- 121
- References
- 12
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. https://app.cochat.ai/papers/10.1046/j.1365-2141.1999.01445.x
- The paper
- Leteurtre, F., Li, X., Guardiola, P., Le Roux, G., Sergère, J. ‐., Richard, P., Carosella, E. D., & Gluckman, E. (1999). Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1999.01445.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.